Company: HROW
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009263
Chunk: 23

Company: HARROW, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 23
---

     51,000 
  
    Trade name 
    4 
     70,000  
     (3,000) 
     -  
     67,000 
  
    State pharmacy licenses 
    25 
     8,000  
     (4,000) 
     -  
     4,000 

    $208,590,000  
    $(27,825,000) 
    $-  
    $180,765,000 

Amortization expense for intangible assets for
the three months ended March 31, 2025 and 2024 was as follows:

 SCHEDULE OF AMORTIZATION EXPENSES FOR INTANGIBLE ASSETS

    2025  
    2024 

    For the Three Months Ended 

    March 31, 

    2025  
    2024 
  
    Patents 
    $3,000  
    $14,000 
  
    Acquired NDAs 
     4,220,000  
     2,530 ,000 
  
    Customer relationships 
     3,000  
     10,000 
  
    Amortization
    expense of intangible assets 
    $4,226,000  
    $2,554,000 

Estimated future amortization expense for the Company’s intangible
assets at March 31, 2025 was as follows:

 SCHEDULE
OF ESTIMATED FUTURE AMORTIZATION EXPENSE

    Remainder of 2025 
    $12,678,000 
  
    2026 
     16,904,000 
  
    2027 
     16,613,000 
  
    2028 
     16,206,000 
  
    2029 
     16,096,000 
  
    Thereafter 
     102,012,000 
  
    Intangible
    assets 
    $180,509,000 

There were no changes to the carrying value of the Company’s
goodwill during the three months ended March 31, 2025 and 2024.

     15 

NOTE 9. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses at March
31, 2025 and December 31, 2024 consisted of the following:

 SCHEDULE OF